Business Wire

The Empire State Building Celebrates Romance in NYC with Valentine’s Day Experiences Throughout the Month of February

7.2.2023 18:56:00 EET | Business Wire | Press release

Share

Love is in the air at the Empire State Building (ESB) with a Valentine’s Day celebration that includes an unforgettable proposal package, tower lighting, giveaways, and month-long special offers for visitors this February.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230207005876/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Empire State Building Valentine's Day 86th Floor Observatory (Photo: Business Wire)

  • Happily Ever Empire – Each couple that books the popular Happily Ever Empire engagement package – that includes priority access and a private tour of the Observatory with celebratory champagne – for Feb. 10-14 will be gifted a four-night, five-day luxury all-inclusive getaway by Sandals Resorts to the resort of their choice (terms and conditions apply) – that includes the brand new Sandals Dunn’s River that opens in Ocho Rios, Jamaica in May – and a $250 gift card towards a wedding dress courtesy of Kleinfeld Bridal. Happily Ever Empire engagement packages are limited to five bookings per day.
  • Getaway Giveaway – Visitors to the Observatory Experience from Feb. 10-14 can enter to win a four-night, five-day all-inclusive resort stay courtesy of Sandals Resorts when they post a photo from the special Valentine’s Day photo corner on the 86th Floor Observatory and tag @sandalsresorts on Instagram.
  • Spread the Love – All visitors who purchase tickets on the ESB website during the month of February will receive 10 percent off online orders from Magnolia Bakery, 25 percent off Valentine’s Day flowers from FTD Flowers, and 20 percent off online orders from Tony’s Chocolonely from Feb. 6-14. On Feb. 11 from 2-8 pm, Tony’s Chocolonely will show love with free chocolate heart samples on the 86th Floor Observatory.
  • Love Lights – On Feb. 14, the Empire State Building’s world-famous tower lights will shine in a pink heartbeat as a Valentine’s Day gift to New York City.

“The reimagined Observatory at the World’s Most Romantic Building draws visitors from around the world for an authentic experience in the heart of New York City,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “Our remarkable views provide visitors with the perfect backdrop for an over-the-top date or proposal.”

“It’s the season of romance and as a brand founded on all things love, Sandals Resorts is here to remind couples of the importance of celebrating love,” said Luisana Suegart, director of public relations for the worldwide representatives of Sandals Resorts. “Recent studies from our Institute of Romance found that a key ingredient in thriving relationships is making the time for connection, with couples feeling closest to each other while on vacation and, forget the chocolates, most agreeing that a getaway is the most romantic gift. Gifting these special couples an idyllic Caribbean escape is our way of celebrating such an important milestone.”

Hi-res imagery and b-roll of the Empire State Building, the scheduled Valentine’s Day tower lighting and all the upcoming exclusive offerings can be downloaded here .

More information about the Empire State Building Observatory can be found online.

About the Empire State Building

The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. Learn more at www.esbnyc.com. Declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 Attraction in the United States in Tripadvisor’s 2022 Travelers’ Choice Best of the Best, and the #1 New York City attraction by Lonely Planet, it welcomes more than 4 million annual visitors from around the world.

Since 2011, the building has been fully powered by renewable wind electricity, and its many floors primarily house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, Twitter, Instagram, Weibo, YouTube, or TikTok.

Source: Empire State Realty Trust, Inc.
Category: Observatory

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

MEDIA:
Empire State Realty Trust
Brock Talbot
347-804-7863
btalbot@esrtreit.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye